The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
To reduce the risk of death from opioid overdose, the FDA is making the following recommendations about the opioid reversal medicine, naloxone.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Heron announced the initiation of a Phase 2 clinical study evaluating CINVANTI injectable emulsion in early hospitalized patients with COVID-19.
read more
OWP has submitted for U.S. patent protection for powder for oral liquid formulation of duloxetine hydrochloride.
read more
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with ...
read more
Palatin announced reinitiation of enrollment of its Phase 2 study with PL9643 for the treatment of dry eye disease.
read more
INTERPHEX, American Pharmaceutical Review, and Pharmaceutical Outsourcing have announced the winners of the 2020 INTERPHEX Exhibitor Awards.
read more
Novartis announced the EC has approved Enerzair® Breezhaler as a maintenance treatment of asthma in adult patients not adequately controlled with a ...
read more
American Pharmaceutical Review has launched a new information resource to cover the development and manufacturing of the highest quality ...
read more
Novartis Pharma announced the Japanese Ministry of Health, Labour and Welfare approved five new treatment options for Japanese patients.
read more
Ardelyx announced the submission of an NDA for tenapanor to the FDA for the control of serum phosphorus in adult patients with chronic kidney disease ...
read more
MediWound has submitted a BLA to the FDA seeking the approval of NexoBrid for eschar removal in adults with deep partial-thickness and/or full-...
read more
IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans.
read more
The FDA has approved a 300 mg single-dose pre-filled pen for Dupixent (dupilumab).
read more
Companion Medical, manufacturers of InPen, the only FDA-cleared smart insulin pen system, has announced that they received FDA expanded clearance for ...
read more